Pharma Synthetic Research Panel — HCP, Patient & Payer Simulations On Demand
Simulate prescribers, patients and payers in minutes — not months — and pressure-test launch, messaging and market access before you spend.
Acumen's pharma synthetic research panel lets commercial, medical and market access teams simulate HCPs, patients, caregivers and payers in minutes. Pressure-test drug launch messaging, clinical narratives, MSL talk tracks and access strategies — without standing up another traditional pharma market research panel.
Audiences modeled
- Specialist physicians (oncology, cardiology, neurology, rare disease)
- Primary care providers and nurse practitioners
- Patients, caregivers and patient advocacy voices
- Payers, PBMs and HEOR decision-makers
- Hospital pharmacy and formulary committee personas
Use cases
- Drug launch readiness — Stress-test launch narratives across HCP segments before sales force training and field deployment.
- Clinical message testing — Validate efficacy, safety and mechanism-of-action stories against MLR-aware physician personas.
- Market access & payer simulation — Model payer objections, value framework reception and formulary decision dynamics before pricing committee.
- Patient journey simulation — Surface lived-experience friction across diagnosis, treatment, adherence and switching moments.
- MSL & advisory simulation — Run a synthetic clinical advisory board to rehearse MSL engagement and KOL conversations.
Why pharma leaders use Acumen for HCP and patient insight
Pharma teams use Acumen alongside their existing research partners — for the launch, MLR and field decisions that move faster than a fielded panel or advisory board can read out. Models run in hours, are calibrated against the brand's own research, and let commercial and medical teams iterate inside the windows traditional research can't reach.
Built for prescribers, patients, payers, and MSL teams
Each persona is calibrated by specialty, practice setting, payer mix, patient population and prescribing behavior — not generic demographics.
Built for the decisions traditional pharma research can't reach in time
Fielded HCP panels and advisory boards remain the standard for high-stakes validation. Acumen is built for the decisions that happen between those studies — iterate on a message Tuesday, retest Wednesday, brief field Friday — keeping every model run connected to the brand's broader commercial picture.
From insight to commercial and market-access action
Outputs are decision-ready: ranked HCP objections, payer access friction by plan type, patient sentiment by journey stage, and MLR-aware risk callouts on every claim. Teams export to brand plans, payer dossiers and field training within hours.
The CXOS layer for pharma brands
Acumen is the Customer Experience Operating System for pharma — a single platform where HCP simulation, patient journey simulation, payer persona modeling and pharma brand tracking AI compound on each other instead of living in disconnected reports.
Where Acumen sits next to traditional HCP panels
Fielded HCP panels and legacy market research remain the right tool for projectable studies. Acumen sits alongside them for the everyday messaging, access and field decisions that fall between studies — running in minutes, calibrated against your own research, and able to model rare disease HCPs, payer committees and MSL conversations that traditional panels struggle to reach at scale.
Frequently asked questions
What is a pharma synthetic research panel?
A pharma synthetic research panel uses calibrated personas — built from your research and category data — to model how HCPs, patients, caregivers and payers will respond to messaging, products and access strategies on the decisions that move too fast for traditional research to reach.
How does Acumen model HCP insights alongside traditional physician panels?
HCP personas are calibrated by specialty, practice setting, payer mix and prescribing behavior, and can be tuned against your existing physician panel data and primary research. Most teams use Acumen for the day-to-day messaging and access decisions that don't justify a fielded study, and reserve traditional panels for the high-stakes reads where statistical projection matters.
Does Acumen replace traditional pharma market research?
No. Acumen extends traditional research to the decisions it can't reach in time — the message tweaks, payer objections and field updates made inside review windows when there's no room for a fielded study. It is not a substitute for IRB-approved patient research, clinical work, or fielded primary research where statistical projection is required.
How does Acumen handle pharma compliance and data accuracy?
Personas react to claims the way MLR reviewers and field-trained HCPs would, surfacing risk language early. The platform does not store PHI, runs on enterprise-grade infrastructure, and gives teams full audit trails on every model run.